Outset Medical, Inc.

Insider Sentiment (TTM):

Last Purchase:-Last Sale:2026-06-03Shares Purchased (TTM):0Shares Sold (TTM):42,863

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:14,540,589Shares Outstanding:18,373,000Institutional Ownership Pct.:79.14%

Earnings Market Reaction:

Filing Date:2026-08-06Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	35	31	35	36	40	76	124	33	38	32	69	36
Short Term Investments	112	126	134	142	145	113	35	142	157	195	135	158
Accounts Receivable Net Current	29	25	28	33	35	37	36	34	34	36	33	35
Inventory Net	47	50	48	49	52	56	59	61	62	56	49	48
Prepaid Expense And Other Assets Current	4	5	6	4	4	5	5	4	5	6	6	6
Assets Current	228	237	251	265	276	287	258	275	295	325	291	284
Restricted Cash Noncurrent	4	4	4	3	3	3	3	3	3	3	3	3
Property Plant And Equipment Net	4	4	5	5	6	7	8	9	11	12	13	14
Operating Lease Right Of Use Asset	5	4	5	3	3	4	4	4	5	5	5	6
Finance Lease Right Of Use Asset	-	0	-	-	-	-	-	-	-	-	-	-
Other Assets Noncurrent	0	0	0	1	1	1	2	0	1	1	1	1
Assets	242	249	264	277	289	301	276	293	315	346	314	308
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current	4	1	1	2	1	1	4	4	5	7	6	3
Accrued Employee Benefits Current	9	9	11	11	10	8	17	15	11	14	19	22
Product Warranty Accrual Classified Current	1	1	1	1	1	2	2	2	2	3	4	4
Contract With Customer Liability Current	14	13	14	15	14	13	13	13	13	13	12	11
Operating Lease Liability Current	2	2	2	2	2	2	2	2	2	2	2	2
Finance Lease Liability Current	-	0	-	-	-	-	-	-	-	-	-	-
Liabilities Current	44	38	38	37	37	34	45	42	43	51	55	53
Contract With Customer Liability Noncurrent	0	0	0	1	1	1	1	0	0	0	0	0
Operating Lease Liability Noncurrent	3	3	3	1	2	2	3	3	4	4	4	5
Finance Lease Liability Noncurrent	-	0	-	-	-	-	-	-	-	-	-	-
Long Term Debt Noncurrent	98	97	96	96	95	94	197	197	197	197	130	97
Liabilities	146	138	138	135	134	131	249	245	246	253	191	155
Stockholders Equity
Preferred Stock Value	0	0	0	4	4	4	0	0	0	0	0	0
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital Common Stock	1,305	1,302	1,298	1,290	1,285	1,281	1,116	1,112	1,105	1,095	1,085	1,075
Accumulated Other Comprehensive Income Loss Net Of…	-0	-0	0	0	0	0	0	0	-0	-0	0	-0
Retained Earnings Accumulated Deficit	-1,208	-1,190	-1,171	-1,152	-1,134	-1,116	-1,090	-1,064	-1,036	-1,002	-962	-923
Stockholders Equity	96	112	127	142	155	170	27	48	69	93	123	152
Liabilities And Stockholders Equity	242	249	264	277	289	301	276	293	315	346	314	308
Preferred Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Preferred Stock Shares Authorized	5	5	5	5	5	5	5	5	5	5	5	5
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Common Stock Shares Authorized	300	300	300	300	300	300	300	300	300	300	300	300
Common Stock Shares Issued	19	19	18	18	18	18	4	4	3	3	3	3
Shares Outstanding	19	19	18	18	18	18	4	4	3	3	3	3

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	4.49%	-2.14%	-13.68%	-	-	-	-	-	-	-	-	-
2025	10.64%	20.09%	16.69%	-1.90%	2.40%	4.02%	-63.63%	-69.35%	-58.49%	-6.19%	18.29%	28.61%
2024	14.07%	17.74%	14.37%	-50.47%	-42.71%	-49.16%	15.46%	46.91%	9.54%	-7.97%	0.82%	78.57%
2023	-	-	-	-	-	-	54.20%	46.61%	-5.15%	-32.40%	-36.14%	-4.36%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	5.19	6.29	6.67	7.09	7.47	8.37	5.69	6.49	6.80	6.42	5.26	5.35
Quick Ratio	4.02	4.84	5.24	5.65	5.93	6.60	4.28	4.95	5.27	5.20	4.27	4.33
Working Capital	183.96M	199.10M	213.25M	227.92M	238.67M	252.34M	212.84M	232.84M	251.70M	274.72M	235.90M	230.75M
Leverage & Debt
Debt to Equity	1.52	1.23	1.08	0.95	0.87	0.77	9.28	5.12	3.59	2.72	1.55	1.02
Interest Coverage TTM	-4.81	-4.89	-4.78	-4.34	-4.17	-4.33	-4.75	-6.00	-8.09	-10.39	-13.39	-15.17
Debt Ratio	0.60	0.55	0.52	0.49	0.46	0.44	0.90	0.84	0.78	0.73	0.61	0.51
Efficiency & Turnover
Asset Turnover TTM	0.44	0.43	0.44	0.42	0.40	0.36	0.39	0.38	0.36	0.35	0.37	0.39
Days Sales Outstanding TTM	99.33	96.55	97.68	102.17	105.57	116.15	110.12	110.95	111.33	103.29	85.46	80.27
Receivables Turnover TTM	3.67	3.78	3.74	3.57	3.46	3.14	3.31	3.29	3.28	3.53	4.27	4.55
Per Share Metrics
Diluted EPS TTM	-3.99	-4.07	-5.37	-4.94	-5.52	-16.17	-36.96	-40.45	-46.03	-49.74	-52.24	-52.76
Free Cash Flow Per Share TTM	-2.78	-1.86	-3.10	-1.58	-2.40	-13.74	-33.85	-36.22	-40.48	-39.94	-40.76	-43.83
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	41.76%	40.64%	39.13%	37.70%	36.46%	35.93%	33.92%	30.97%	28.23%	24.61%	22.24%	20.14%
Operating Profit Margin TTM	-56.06%	-57.17%	-55.83%	-59.08%	-66.19%	-80.56%	-99.72%	-112.32%	-129.25%	-130.48%	-130.22%	-130.61%
Net Profit Margin TTM	-63.06%	-63.65%	-68.34%	-73.12%	-82.06%	-98.74%	-112.57%	-122.84%	-136.72%	-134.93%	-132.54%	-133.19%
Growth Metrics
Net Revenue Growth (1Y)	-1.26%	2.01%	5.09%	4.65%	2.47%	-7.84%	-12.80%	-13.00%	-9.94%	5.74%	13.00%	18.25%
Net Income Growth (1Y)	-24.12%	-34.24%	-36.20%	-37.70%	-38.50%	-32.56%	-25.94%	-19.76%	-6.50%	-0.74%	6.04%	7.92%
EPS Growth (1Y)	-27.69%	-74.81%	-85.47%	-87.79%	-88.01%	-67.49%	-29.26%	-23.32%	-11.72%	-4.82%	2.99%	4.07%
Valuation Metrics
P/E TTM	-1.08	-0.94	-0.69	-2.86	-3.48	-0.68	-0.45	-0.25	-1.25	-0.67	-1.55	-3.09
P/B TTM	0.83	0.63	0.44	1.76	2.20	0.46	2.15	0.74	2.91	1.21	2.18	3.57
P/S TTM	0.68	0.60	0.47	2.09	2.86	0.68	0.51	0.31	1.72	0.90	2.06	4.12
Market Cap	80.43M	70.55M	56.43M	251.10M	340.84M	77.84M	57.66M	35.38M	199.70M	112.99M	268.41M	543.32M
Enterprise Value	143.08M	136.95M	117.66M	310.18M	396.10M	96.03M	131.02M	199.28M	358.83M	277.62M	330.01M	603.81M
Calculated Values
Free Cash Flow TTM	-51.76M	-34.25M	-47.13M	-28.13M	-42.61M	-96.74M	-117.22M	-126.18M	-140.00M	-135.51M	-134.81M	-145.93M
Net Debt	62.64M	66.40M	61.23M	59.09M	55.26M	18.19M	73.36M	163.90M	159.14M	164.64M	61.60M	60.49M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-06-03Sale

Owner: Gaeta, Renee

Title: Chief Financial Officer

Shares: 17,672

Price/Share: $4.94

Value: $87,299.68

Shares Owned: 113,753

Relationship: Officer

Ownership: Direct

2026-05-15Sale

Owner: Trigg, Leslie

Title: Chair and CEO

Shares: 3,445

Price/Share: $3.70

Value: $12,746.50

Shares Owned: 98,874

Relationship: Director,Officer

Ownership: Direct

2026-05-15Sale

Owner: Brottem, John L.

Title: General Counsel

Shares: 2,638

Price/Share: $3.70

Value: $9,760.60

Shares Owned: 30,277

Relationship: Officer

Ownership: Direct

2026-05-15Sale

Owner: Nash, Marc

Title: EVP Operations R&D & Service

Shares: 1,582

Price/Share: $3.70

Value: $5,853.40

Shares Owned: 38,393

Relationship: Officer

Ownership: Direct

2026-02-17Sale

Owner: Brottem, John L.

Title: General Counsel

Shares: 2,842

Price/Share: $3.35

Value: $9,520.70

Shares Owned: 32,935

Relationship: Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-06-03	Gaeta, Renee	Officer	Chief Financial Officer	Direct	Sale	17,672	4.94	$87,299.68	113,753	4
2026-05-15	Trigg, Leslie	Director,Officer	Chair and CEO	Direct	Sale	3,445	3.70	$12,746.50	98,874	4
2026-05-15	Brottem, John L.	Officer	General Counsel	Direct	Sale	2,638	3.70	$9,760.60	30,277	4
2026-05-15	Nash, Marc	Officer	EVP Operations R&D & Service	Direct	Sale	1,582	3.70	$5,853.40	38,393	4
2026-02-17	Brottem, John L.	Officer	General Counsel	Direct	Sale	2,842	3.35	$9,520.70	32,935	4
2026-02-17	Nash, Marc	Officer	EVP Operations R&D & Service	Direct	Sale	1,817	3.35	$6,086.95	39,988	4
2026-02-17	Trigg, Leslie	Director,Officer	Chair and CEO	Direct	Sale	3,361	3.35	$11,259.35	102,342	4
2026-01-21	Trigg, Leslie	Director,Officer	Chair and CEO	Direct	Sale	2,120	5.05	$10,706.00	105,703	4
2026-01-21	Nash, Marc	Officer	EVP Operations R&D & Service	Direct	Sale	980	4.98	$4,880.40	41,805	4
2026-01-21	Brottem, John L.	Officer	General Counsel	Direct	Sale	1,180	5.01	$5,911.80	35,777	4
2026-01-07	Trigg, Leslie	Director,Officer	Chair and CEO	Direct	Sale	1,795	4.27	$7,664.65	119,617	4
2026-01-07	Brottem, John L.	Officer	General Counsel	Direct	Sale	224	4.27	$956.48	46,271	4
2026-01-07	Nash, Marc	Officer	EVP Operations R&D & Service	Direct	Sale	108	4.27	$461.16	48,160	4
2025-12-01	Drexler, Karen	Director	-	Direct	Sale	1,548	4.37	$6,764.76	10,650	4
2025-11-17	Nash, Marc	Officer	EVP Operations R&D & Service	Direct	Sale	247	4.60	$1,136.20	48,268	4
2025-11-17	Trigg, Leslie	Director,Officer	Chair and CEO	Direct	Sale	916	4.60	$4,213.60	121,412	4
2025-11-17	Brottem, John L.	Officer	General Counsel	Direct	Sale	388	4.60	$1,784.80	46,495	4
2025-08-15	Nash, Marc	Officer	SVP Operations and R&D	Direct	Sale	243	12.88	$3,129.84	42,898	4
2025-08-15	Brottem, John L.	Officer	General Counsel	Direct	Sale	383	12.88	$4,933.04	46,883	4
2025-08-15	Trigg, Leslie	Director,Officer	Chair and CEO	Direct	Sale	904	12.88	$11,643.52	122,328	4
2025-05-15	Nash, Marc	Officer	SVP Operations and R&D	Direct	Sale	252	17.82	$4,490.64	13,465	4
2025-05-15	Brottem, John L.	Officer	General Counsel	Direct	Sale	396	17.82	$7,056.72	11,273	4
2025-05-15	Ahmed, Nabeel	Officer	Chief Financial Officer	Direct	Sale	584	17.81	$10,401.04	16,096	4
2025-05-15	Trigg, Leslie	Director,Officer	Chair and CEO	Direct	Sale	935	17.80	$16,643.00	58,129	4
2025-02-18	Nash, Marc	Officer	SVP Operations and R&D	Direct	Sale	4,204	0.90	$3,783.60	200,764	4
2025-02-18	Trigg, Leslie	Director,Officer	Chair and CEO	Direct	Sale	14,611	0.90	$13,149.90	880,969	4
2025-02-18	Ahmed, Nabeel	Officer	Chief Financial Officer	Direct	Sale	8,659	0.90	$7,793.10	250,210	4
2025-02-18	Brottem, John L.	Officer	General Counsel	Direct	Sale	6,145	0.90	$5,530.50	175,043	4
2025-01-21	Nash, Marc	Officer	SVP Operations and R&D	Direct	Sale	23,221	0.80	$18,576.80	204,968	4
2025-01-21	Brottem, John L.	Officer	General Counsel	Direct	Sale	32,930	0.80	$26,344.00	181,188	4
2025-01-21	Ahmed, Nabeel	Officer	Chief Financial Officer	Direct	Sale	34,288	0.80	$27,430.40	258,869	4
2025-01-21	Trigg, Leslie	Director,Officer	Chair and CEO	Direct	Sale	65,236	0.80	$52,188.80	895,580	4
2025-01-13	Brottem, John L.	Officer	General Counsel	Direct	Sale	20,492	0.81	$16,598.52	205,028	4
2025-01-13	Nash, Marc	Officer	SVP Operations and R&D	Direct	Sale	15,011	0.81	$12,158.91	222,291	4
2025-01-13	Ahmed, Nabeel	Officer	Chief Financial Officer	Direct	Sale	29,031	0.81	$23,515.11	279,901	4
2025-01-13	Trigg, Leslie	Director,Officer	Chair and CEO	Direct	Sale	33,227	0.81	$26,913.87	861,397	4
2025-01-07	Nash, Marc	Officer	SVP Operations and R&D	Direct	Sale	720	1.29	$928.80	237,302	4
2025-01-07	Trigg, Leslie	Director,Officer	Chair and CEO	Direct	Sale	10,227	1.29	$13,192.83	894,624	4
2025-01-07	Brottem, John L.	Officer	General Counsel	Direct	Sale	1,572	1.29	$2,027.88	225,520	4
2025-01-07	Ahmed, Nabeel	Officer	Chief Financial Officer	Direct	Sale	1,835	1.29	$2,367.15	308,932	4
2024-11-15	Trigg, Leslie	Director,Officer	Chair and CEO	Direct	Sale	5,645	0.80	$4,516.00	904,851	4
2024-11-15	Nash, Marc	Officer	SVP Operations and R&D	Direct	Sale	1,375	0.80	$1,100.00	238,022	4
2024-11-15	Brottem, John L.	Officer	General Counsel	Direct	Sale	3,203	0.80	$2,562.40	227,092	4
2024-11-15	Ahmed, Nabeel	Officer	Chief Financial Officer	Direct	Sale	4,221	0.80	$3,376.80	310,767	4
2024-08-15	Brottem, John L.	Officer	General Counsel	Direct	Sale	3,011	0.84	$2,529.24	230,295	4
2024-08-15	Ahmed, Nabeel	Officer	Chief Financial Officer	Direct	Sale	3,971	0.84	$3,335.64	314,988	4
2024-08-15	Trigg, Leslie	Director,Officer	Chair and CEO	Direct	Sale	5,308	0.84	$4,458.72	910,496	4
2024-08-15	Nash, Marc	Officer	SVP Operations and R&D	Direct	Sale	1,293	0.84	$1,086.12	239,397	4
2024-07-24	Nash, Marc	Officer	SVP Operations and R&D	Direct	Sale	723	4.02	$2,906.46	240,690	4
2024-06-12	Brottem, John L.	Officer	General Counsel	Direct	Sale	10,569	4.78	$50,519.82	233,306	4
2024-06-03	Grossman, D Keith	Director	-	Direct	Sale	38,117	3.77	$143,701.09	47,805	4
2024-05-16	Trigg, Leslie	Director,Officer	Chair and CEO	Direct	Sale	5,237	3.53	$18,486.61	915,804	4
2024-05-16	Ahmed, Nabeel	Officer	Chief Financial Officer	Direct	Sale	3,918	3.53	$13,830.54	318,959	4
2024-05-16	Nash, Marc	Officer	SVP Operations and R&D	Direct	Sale	1,097	3.53	$3,872.41	241,413	4
2024-05-16	Brottem, John L.	Officer	General Counsel	Direct	Sale	2,972	3.53	$10,491.16	243,875	4
2024-05-10	Racine, Jean-Olivier	Officer	Chief Technology Officer	Direct	Sale	8,306	3.27	$27,160.62	265,325	4
2024-03-15	Nash, Marc	Officer	SVP Operations and R&D	Direct	Sale	2,391	2.13	$5,092.83	242,510	4
2024-03-01	Ahmed, Nabeel	Officer	Chief Financial Officer	Direct	Sale	1,584	3.15	$4,989.60	322,877	4
2024-02-15	Nash, Marc	Officer	SVP Operations and R&D	Direct	Sale	617	3.57	$2,202.69	243,100	4
2024-02-15	Racine, Jean-Olivier	Officer	Chief Technology Officer	Direct	Sale	1,866	3.57	$6,661.62	271,830	4
2024-02-15	Williamson, Steven S.	Officer	Chief Commercial Officer	Direct	Sale	2,500	3.57	$8,925.00	320,347	4
2024-02-15	Ahmed, Nabeel	Officer	Chief Financial Officer	Direct	Sale	4,403	3.57	$15,718.71	312,594	4
2024-02-15	Brottem, John L.	Officer	General Counsel	Direct	Sale	3,341	3.57	$11,927.37	245,046	4
2024-02-15	Trigg, Leslie	Director,Officer	Chair and CEO	Direct	Sale	5,320	3.57	$18,992.40	833,091	4
2024-01-16	Racine, Jean-Olivier	Officer	Chief Technology Officer	Direct	Sale	723	4.29	$3,101.67	273,696	4
2024-01-16	Trigg, Leslie	Director,Officer	Chair and CEO	Direct	Sale	8,126	4.29	$34,860.54	838,411	4
2024-01-16	Ahmed, Nabeel	Officer	Chief Financial Officer	Direct	Sale	1,726	4.29	$7,404.54	316,997	4
2024-01-16	Nash, Marc	Officer	SVP Operations and R&D	Direct	Sale	678	429.00	$290,862.00	243,717	4
2024-01-16	Williamson, Steven S.	Officer	Chief Commercial Officer	Direct	Sale	996	4.29	$4,272.84	322,847	4
2024-01-16	Porter, Stacey L.	Officer	Chief People Officer	Direct	Sale	768	4.29	$3,294.72	61,448	4
2024-01-16	Brottem, John L.	Officer	General Counsel	Direct	Sale	1,480	4.29	$6,349.20	248,387	4
2024-01-08	Williamson, Steven S.	Officer	Chief Commercial Officer	Direct	Sale	7,055	5.49	$38,731.95	105,939	4
2024-01-08	Ahmed, Nabeel	Officer	Chief Financial Officer	Direct	Sale	10,709	5.49	$58,792.41	76,819	4
2024-01-08	Porter, Stacey L.	Officer	Chief People Officer	Direct	Sale	4,766	5.49	$26,165.34	58,630	4
2024-01-08	Trigg, Leslie	Director,Officer	Chair and CEO	Direct	Sale	14,188	5.49	$77,892.12	389,099	4
2024-01-08	Racine, Jean-Olivier	Officer	Chief Technology Officer	Direct	Sale	3,905	5.49	$21,438.45	73,781	4
2024-01-08	Brottem, John L.	Officer	General Counsel	Direct	Sale	7,344	5.49	$40,318.56	48,807	4
2023-11-16	Trigg, Leslie	Director,Officer	Chair and CEO	Direct	Sale	3,175	4.76	$15,113.00	403,287	4
2023-11-16	Nash, Marc	Officer	SVP Operations and R&D	Direct	Sale	562	4.76	$2,675.12	44,757	4
2023-11-16	Williamson, Steven S.	Officer	Chief Commercial Officer	Direct	Sale	3,584	4.76	$17,059.84	112,994	4
2023-11-16	Porter, Stacey L.	Officer	Chief People Officer	Direct	Sale	671	4.76	$3,193.96	63,396	4
2023-11-16	Ahmed, Nabeel	Officer	Chief Financial Officer	Direct	Sale	1,643	4.76	$7,820.68	87,528	4
2023-11-16	Brottem, John L.	Officer	General Counsel	Direct	Sale	1,431	4.76	$6,811.56	56,151	4
2023-11-16	Racine, Jean-Olivier	Officer	Chief Technology Officer	Direct	Sale	790	4.76	$3,760.40	77,686	4
2023-09-01	Ahmed, Nabeel	Officer	Chief Financial Officer	Direct	Sale	545	13.61	$7,417.45	89,171	4
2023-08-16	Ahmed, Nabeel	Officer	Chief Financial Officer	Direct	Sale	1,565	15.10	$23,631.50	89,171	4
2023-08-16	Williamson, Steven S.	Officer	Chief Commercial Officer	Direct	Sale	635	15.10	$9,588.50	116,577	4
2023-08-16	Nash, Marc	Officer	SVP Operations and R&D	Direct	Sale	535	15.10	$8,078.50	44,998	4
2023-08-16	Brottem, John L.	Officer	General Counsel	Direct	Sale	1,364	15.10	$20,596.40	57,581	4
2023-08-16	Porter, Stacey L.	Officer	Chief People Officer	Direct	Sale	638	15.10	$9,633.80	64,066	4
2023-08-16	Racine, Jean-Olivier	Officer	Chief Technology Officer	Direct	Sale	752	15.10	$11,355.20	78,475	4
2023-08-16	Trigg, Leslie	Director,Officer	Chair and CEO	Direct	Sale	3,028	15.10	$45,722.80	406,461	4
2023-08-01	Ahmed, Nabeel	Officer	Chief Financial Officer	Direct	Sale	990	20.07	$19,869.30	90,736	4
2023-08-01	Trigg, Leslie	Director,Officer	Chair and CEO	Direct	Sale	20,000	20.22	$404,400.00	409,489	4
2023-07-19	Brottem, John L.	Officer	General Counsel	Direct	Sale	1,415	20.00	$28,300.00	58,945	4
2023-07-03	Trigg, Leslie	Director,Officer	Chair and CEO	Direct	Sale	20,000	20.90	$418,000.00	409,489	4
2023-07-03	Ahmed, Nabeel	Officer	Chief Financial Officer	Direct	Sale	990	21.70	$21,483.00	91,726	4
2023-06-20	Brottem, John L.	Officer	General Counsel	Direct	Sale	1,414	21.97	$31,065.58	58,945	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

79.14%

Inst. Shares: 14,540,589

Shares Outstanding: 18,373,000

2025-12-31

98.87%

Inst. Shares: 15,039,342

Shares Outstanding: 15,211,000

2025-09-30

97.82%

Inst. Shares: 17,394,996

Shares Outstanding: 17,783,000

2025-06-30

95.06%

Inst. Shares: 16,866,510

Shares Outstanding: 17,743,000

2025-03-31

183.09%

Inst. Shares: 12,885,872

Shares Outstanding: 7,038,000

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	14,540,589	18,373,000	79.14%
2025-12-31	15,039,342	15,211,000	98.87%
2025-09-30	17,394,996	17,783,000	97.82%
2025-06-30	16,866,510	17,743,000	95.06%
2025-03-31	12,885,872	7,038,000	183.09%
2024-12-31	17,753,227	3,463,000	-
2024-09-30	22,259,309	3,484,000	-
2024-06-30	45,676,151	3,458,000	-
2024-03-31	46,394,150	3,393,000	-
2023-12-31	46,921,896	3,307,520	-
2023-09-30	48,665,074	3,329,197	-
2023-06-30	48,204,395	3,265,032	-
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

Outset Medical, Inc. (OM) — SEC Financial Statements & Analysis

Outset Medical, Inc. (OM) is a electromedical & electrotherapeutic apparatus company, incorporated in DE. Outset Medical, Inc. trades on Nasdaq as: OM. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Outset Medical, Inc. reported a -1.26% year-over-year revenue growth, a Gross Profit Margin of 41.76% (TTM), a Debt-to-Equity ratio of 1.52x, a Price-to-Sales (P/S) ratio of 0.68x (TTM), a Price-to-Book (P/B) ratio of 0.83x (TTM), at a market cap of $80.43M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: -1.26%
Gross Profit Margin TTM: 41.76%
Debt To Equity: 1.52x
P/S TTM: 0.68x
P/B TTM: 0.83x
Market Cap: $80.43M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Outset Medical, Inc. in?

Outset Medical, Inc. (OM) operates in the Electromedical & Electrotherapeutic Apparatus industry.

What is OM's market cap?

Outset Medical, Inc. (OM) has a market capitalization of $80.43M as of 2026-06-30.

What exchange does OM trade on?

Outset Medical, Inc. (OM) trades on the Nasdaq.

Where is Outset Medical, Inc. incorporated?

Outset Medical, Inc. is incorporated in DE.